Clinical Gastroenterology Vol.38 No.07 ( Jun, 2023)

Thesis List

• 0-2 Editorial

• 1 Checkpoints of the Medical Interview and the Physical Examination
  Isao Hidaka

• 2-1 When Abnormal Serum Enzyme Levels are Observed
  Sachiyo Yoshio

• 2-2 Disorders of Bilirubin Clearance
  Hironao Okubo

• 2-3 Examinations for Hepatic Function
  Toshifumi Tada

• 2-4 Role of Tumor Markers in Surveillance, Diagnosis, Prognosis Prediction, and Treatment Response in Liver Cancer
  Hiroko Setoyama

• 2-5 Checkpoints for Liver Fibrosis Markers
  Kazumasa Sakamoto

• 2-6 Epidemiology of Liver Cirrhosis in Japan
  Yoshinari Asaoka

• 2-7 Epidemiology of Hepatocellular Carcinoma in Japan
  Ryosuke Tateishi

• 3 Checkpoints for Hepatitis Virus Markers
  Takeji Umemura

• 4-1 Ultrasound Imaging in Patients with Chronic Hepatitis
  Takashi Nishimura

• 4-2 Liver Stiffness Measurement in Patients with Chronic Liver Disease
  Nobuharu Tamaki

• 4-3 Differentiation of Space Occupying Lesion (SOL) in Liver
  Hidenori Kido

• 5-1 Diagnostic and Therapeutic Strategies for Drug-induced Liver Injury
  Takanori Ito

• 5-2 Differential Diagnosis of Viral Liver Injury, Other than Hepatitis Virus
  Masatsugu Ohara

• 5-3 Coagulation Disorders in Cirrhosis
  Suguru Ogura

• 5-4 Diagnosis of Autoimmune Hepatitis
  Masanori Abe

• 5-5 The Differential Diagnosis of Cholestatic Liver Disease
  Kazumichi Abe

• 5-6 Diagnosis of Alcoholic Hepatitis and Nonalcoholic Steatohepatitis
  Hideki Fujii

• 6-1 Endoscopic Examination for Assessing Esophagogastric Varices
  Yuko Nagaoki

• 6-2 Ascites
  Hideto Kawaratani

• 6-3 Diagnosis of Hepatic Encephalopathy
  Yasuteru Kondo

• 7 Checkpoints for Diagnosis of Hepatocellular Carcinoma in Chronic Liver Disease
  Mina Nakagawa

• 8 Treatment of Acute Hepatitis
  Ryosuke Kasuga

• 9-1 Goals of Chronic HBV Treatment
  Masaru Enomoto

• 9-2 Antiviral Treatment for Chronic Hepatitis B: Interferon and Nucleos(t)ide Analogues
  Tetsuya Hosaka

• 9-3 Checkpoints of Drug Therapies for Chronic Hepatitis C
  Hitomi Sezaki

• 9-4 Checkpoints After Hepatitis C Virus Elimination in Patients with Chronic Hepatitis C
  Hayato Hikita

• 9-5 Pharmacotherapy for Autoimmune Hepatitis
  Kazuhito Kawata

• 10 Checkpoints for Treatment of Alcohol-associated/-related Liver Disease
  Kazuyoshi Kon

• 11 Checkpoints for the Treatment of NAFLD
  Yoshihiro Kamada

• 12 Checkpoints in Therapeutic Strategy of Acute Liver Failure
  Yoshihito Uchida

• 13 Key Information of Treatment for PBC and PSC
  Satoru Joshita

• 14 Checkpoints of Treatment for Esophagogastric Varices
  Tsuyoshi Ishikawa

• 15 The Treatment of Ascites in Liver Cirrhosis Patients
  Hiroyuki Nakanishi

• 16 Checkpoints for Hepatic Encephalopathy Treatment
  Tatsunori Hanai

• 17 Checkpoints for Portal Vein Thrombosis Treatments
  Hisashi Hidaka

• 18 Checkpoints of Pulmonary Complications Accompanied with Portal Hypertension
  Tomomi Kogiso

• 19-1 Local Ablation Therapy
  Yasunori Minami

• 19-2 Interventional Radiology Treatments for Hepatocellular Carcinoma
  Sadahisa Ogasawara

• 19-3-1 Systemic Therapy for Hepatocellular Carcinoma According to the Current Japanese Clinical Practice Guideline
  Kaoru Tsuchiya

• 19-3-2 Outcomes and Future Perspectives of Systemic Chemotherapy for Hepatocellular Carcinoma
  Takahiro Kodama

• 20 Surgery and Living Donor Liver Transplantation for Hepatocellular Carcinoma
  Yoshikuni Kawaguchi

• 21 Checkpoints for Lifestyle Guidance for Chronic Hepatitis and Cirrhosis
  Dan Nakano

• 22 The New Definition of "MAFLD" for Fatty Liver
  Tsubasa Tsutsumi

• 23 Secondary Sarcopenia Due to Chronic Liver Disease
  Atsushi Hiraoka

• 24 Chronic Liver Disease and Gut Microbioma
  Atsunori Tsuchiya